Clinica Chimica Acta 1999: Vol 289 Index

7 Pages·1999·1.2 MB·English

Clinica Chimica Acta 289 (1999) 183-184
www.elsevier.com/locate/clinchim
Author index
Volume 289 (1999)
Abraham, P., Wilfred, G., Cathrine, S.P., Oxidative Engler, H., Oettli, R.E., Riesen, W.F., Biochemical
damage to the lipids and proteins of the lungs, markers of bone turnover in patients with thyroid
testis and kidney of rats during carbon tetra dysfunctions and in euthyroid controls: a cross
chloride intoxication 289, 177 sectional study 289, 159
Acebes, C., de la Piedra, C., Traba, M.L., Seibel,
M.J., Garcia Martin, C., Armas, J., Herrero Fukuoka, M., see Maehira, F 289, 133
Beaumont, G., Biochemical markers of bone
remodeling and bone sialoprotein in ankylosing Galliano, M., Kragh-Hansen, | Tarnoky, A.l
spondylitis 289, 99 Chapman, J.C., Campagnoli, M., Minchiotti, I
Addolorato, G., see Capristo, E 289, 11 Genetic variants showing apparent hot-spots in
Akinloye, O., see Olatunde Farombi, E 289, | the human serum albumin gene 289, 45
Akinmoladun, C.O., see Olatunde Farombi, E Garcia Martin, C., see Acebes, ¢ 289, 99
289, | Gasbarrini, G., see Capristo, E 289, 11
Ando, T., see Gotoh, Y 289, 89 Gotoh, K., see Uehara, S$ 289, 33
Arienti, G., Saccardi, C., Carlini, E., Verdacchi, R.., Gotoh, Y., Okamoto, Y., Uemura, O., Mori, N.,
Palmerini, C.A., Distribution of lipid and protein Tanaka, S., Ando, T., Nishida, M., Determi
in human semen fractions 289, 111 nation of age-related changes in human soluble
Armas, J., see Acebes, C 289, 99 interleukin 2 receptor in body fluids of normal
Asato, T., see Maehira, F 289, 133 subjects as a control value against disease states
289, 89
‘ampagnoli, M., see Galliano, M 289, 45 Greco, AV., see Capristo, I 289, 11
apristo, E., Mingrone, G., De Gaetano, A., Ad
dolorato, G., Greco, AV., Gasbarrini, G., A new Handa, H., see Uehara, S 289
HPLC method for the direct analysis of tri Herrero-Beaumont, G., see Acebes, C 289, 99
glycerides of dicarboxylic acids in biological Hirayama, A., see Uehara, S
samples 289, 11 Honjo, K., see Uehara, S
‘arlini, E., see Arienti, G 289, 111
‘athrine, S.P., see Abraham, P. 289, 177 Irino, T., see Muramoto, Y 289, 69
Chapman, J.C., see Galliano, M 289, 45
Coe, F.L., see Nakagawa, Y 289, 57 Jenkins, M.A., Ratnaike, S., Capillary isoelectric
focusing of haemoglobin variants in the clinical
Danielsson, B., see Raghavan, V 289, 145 laboratory 289, 121
De Gaetano, A., see Capristo, E 289, 11
de la Piedra, C., see Acebes, C 289, 99 Kodama, H., see Zhang, J 289, 79
Kokcam, I., Nazuroglu, M., Antioxidants and lipid
Eguchi, Y., see Maehira, I 289, 133 peroxidation status in the blood of patients with
Emerole, G.O., see Olatunde Farombi, E 289, | psoriasis 289, 23
PII: $009-8981(99)00201-6
Author index 289 (1999)
Kragh-Hansen, U., see Galliano, M 289, 45 Ramanathan, K., see Raghavan, V 289, 145
Ratnaike, S., see Jenkins, M.A 289, 121
Ma, D., see Zhang, J 289, 79 Riesen, W.F., see Engler, H 289, 159
Maehira, F.. Miyagi, L., Asato, T., Eguchi, Y Saccardi, C., see Arienti, G 289. 111
Takei, H., Nakatsuki, K., Fukuoka, M., Zaha, F Seibel, M.J., see Acebes, C 289, 99
Alterations of protein kinase C, 8-hydroxy Sundaram, PV., see Raghavan, V 289, 145
deoxyguanosine, and K-ras oncogene in rat
lungs exposed to passive smoking 289, 133 Takei, H., see Maehira, | 289, 133
Matsushita, M., see Muramoto, Y 289. 69 Tanaka, S., see Gotoh, Y 289, 89
Meng, Z., see Zhang, J 289, 79 Tarnoky, A.L., see Galliano, M 289, 45
Minchiotti, L., see Galliano, M 289, 45 Traba, M.L., see Acebes, ( 289, 99
Mingrone, G., see Capristo, I
Miyagi, I., see Maehira, F Uehara, S., Gotoh, K.., Handa, H., Honjo, K.,
Mori, N., see Gotoh, Y Hirayama, A Process of carboxylation of
Muramoto, Y., Matsushita, M., Irino, T Reduction glutamic acid residues in the Gla domain of
of reaction differences between human mercap human des-y-carboxyprothrombin 289, 33
talbumin and human nonmercaptalbumin mea Uemura, O., see Gotoh, Y 289, 89
sured by the bromcresol purple method 289
69 Verdacchi, R., see Arienti, G 289, 111
Nakagawa, Y., Coe, F.L., A modified cyanide-nitro Wilfred, G., see Abraham, P. 289, 177
prusside method for quantifying urinary cystine
concentration that corrects for creatinine interfer Xu, S., see Zhang, J 289, 79
ence 289, 57
Nakatsuki, K., see Maehira, I 289, 133 Yamamoto, T., Yonemasu, K Multiple molecular
Nazuroglu, M., see Kékcam I 289, 23 forms of serum immunoglobulin M in a patient
Nishida, M., see Gotoh, Y 289, 89 with Waldenstr6m’s macroglubulinemia 289
173
Oecttli, R.E., see Engler, H 289, 159 Yonemasu, K., see Yamamoto, T 289, 173
Okamoto, Y., see Gotoh, Y 289. 89
Olatunde Farombi, E., Akinloye, O., Akinmoladun Zaha, F., see Machira, F 289, 133
C.O., Emerole, G.O., Hepatic drug metabolizing Zhang, J.. Meng, Z., Zhang, M., Ma, D Xu, §
enzyme induction and serum triacylglycerol Kodama, H Effect of six steroidal saponins
elevation in rats treated with chlordiazepoxide isolated from anemarrhenae rhizoma on platelet
griseofulvin, rifampicin and phenytoin 289, | aggregation and hemolysis in human blood
289, 79
Palmerini, C.A., see Arienti, G 289. 111 Zhang, M see Zhang, J 289, 79
Raghavan, V.. Ramanathan, K., Sundaram, PV
Danielsson, B An enzyme thermistor-based
assay for total and free cholesterol 289. 145
Clinica Chimica Acta 289 (1999)
www.elsevier.com/locate/clinchim
Subject index
Volume 289 (1999)
5,5'-dithiobis(2-nitrobenzoic acid); Serum al Bone sialoprotein; Ankylosing spondylitis; Osteo
bumin; Bromcresol purple method; Human met penia; Procollagen | propeptides; Pyridinolines
captalbumin; Human nonmercaptalbumin; So Telopeptides 289, 99
dium dodecylsulfate 289, 69
Bromcresol purple method; Serum albumin
$-Hydroxydeoxyguanosine,; Protein kinease C; K Human mercaptalbumin; Human nonmercaptal
ras; Lung cancer; Passive smoking 289, 133 bumin; Sodium dodecylsulfate; 5,5'-dithiobis(2
nitrobenzoic acid) 289, 69
Albumin variants: Bisalbuminaemia; Proalbumin
variants; Hypermutability; Functional conse ‘apillary electrophoresis; Clinical laboratory
quences of albumin variation 289, 45 Capillary isoelectric focusing: Haemoglobin var
iants 289, 121
Anemarrhenae rhizoma; Platelet aggregation
Hemolysis, Steroidal saponins 289, 79 apillary isoelectric focusing; Capillary electr
phoresis; Clinical laboratory Haemoglobin var
Ankylosing spondylitis; Osteopenia; Procollagen |
iants 289, 121
propeptides Pyridinolines Telopeptides sone
sialoprotein 289, 99
arbon tetrachloride, Oxidative dam:
— 289, 177
Antioxidants; Psoriasis; Lipid peroxidation; Vita
min E; Beta carotene. 289, 23 ; z
arboxylation; Des-y-carboxyprothrombin; Gla
Beta carotene; Psoriasis; Lipid peroxidation; Anti dwoomnagiyn ; -y-Caerboxygleutamic acid; Glutaemice acid
oxidants; Vitamin E 289, 23 289, 33
Bile; Free cholesterol; Total cholesterol; Enzyme hlordiazepoxide Serum triacylglycerol; Griseo
i he rug metaboliz
thermistor; Serum; Flow injection analysis; Gall fulvin; Rifampicin; Phenytoin; Drug metaboliz
stones: HDL-C: LDL-C 289 145 ing enzyme induction 289, |
Biochemical bond markers; Thyroid; Pyridinoline Cholesterol; Semen; Prostasomes; Lipid; Protein
cross-links; Thyroid dysfunction 289, 159 Phospholipid 289, 111
Bisalbuminaemia; Albumin variants; Proalbumin Clinical laboratory; Capillary electrophoresis;
variants; Hypermutability; Functional conse Capillary isoelectric focusing; Haemoglobin var
quences of albumin variation 289, 45 iants 289, 12]
PII: S009-8981(99)00202-8
186 Subject index vol. 289 (1999)
Colorimetry; Cystine; Cystinuria Nephrolithiasis Glutamic acid; Des-y-carboxyprothrombin; Car
289, 57 boxylation; Gla-domain; -y-Carboxyglutamic acid
289, 33
Cystine; Cystinuria; Colorimetry Nephrolithiasis
289, 57 Griseofulvin; Serum _ triacylglycerol; Chlor-
diazepoxide; Rifampicin; Phenytoin; Drug
Cystinuria; Cystine; Colorimetry; Nephrolithiasis metabolizing enzyme induction 289, |
289, 57
HDL-C; Free cholesterol; Total cholesterol; En-
Des-y-carboxyprothrombin; Carboxylation; Gla- zyme thermistor; Bile; Serum; Flow injection
domain; ‘y-C “arboxyglutamic acid; Glutamic acid analysis; Gall stones; LDL-C 289, 145
289, 33
Haemoglobin variants; Capillary electrophoresis;
Dicarboxylic acids; Dodecanedioic acid; High-per- Clinical laboratory; Capillary isoelectric focusing
formance liquid chromatography; Sebacic acid; 289, 121
Triglycerides 289, 11
Hemolysis, Steroidal saponins; Anemarrhenae
Dodecanedioic acid; Dicarboxylic acids: ; High-per- rhizoma; Platelet aggregation 289, 79
formance liquid chromatography; Sebacic acid;
Triglycerides 289, 11
High-performance liquid chromatography; Di-
carboxylic acids; Dodecanedioic acid; Sebacic
Drug metabolizing enzyme induction; Serum
. ‘ acid; Triglycerides 289, 11
triacylglycerol; Chlordiazepoxide; Griseofulvin;
Rifampicin; Phenytoin 289, |
Human mercaptalbumin; Serum albumin; Brom
cresol purple method; Human nonmercaptal-
ELAST*™; Soluble interleukin 2 receptors (sIL-2R);
bumin; Sodium dodecylsulfate; 5,5‘-dithiobis(2-
Human 289, 89
nitrobenzoic acid) 289, 69
Enzyme thermistor, Free cholesterol: Total ‘ .
. : Human nonmercaptalbumin; Serum albumin;
cholesterol; Bile; Serum; Flow injection analysis; B ; ’ hod: H '
Ga: ll stones; HDL-C;_ LDL-C . 289, 145“ romcr—es ol puarpele meotn hod; Hu_ma n mercaptPa l-
bumin; Sodium dodecylsulfate; 5,5‘-dithiobis(2
E+ nzyme-li*n ked i. mmunosorbent assay; War lden- nitr obenenzZooiicc ac~i10 d ) 289, 69
str6m’s macroglubulinemia; Immunoglobulin M;
Human; Soluble interleukin 2 receptors (sIL-2R);
Nephelometry 289, 173
ELAST” 289, 89
Flow injection analysis; Free cholesterol; Total
Hypermutability; Bisalbuminaemia; Albumin var
cholesterol; Enzyme thermistor; Bile; Serum;
Gall stones; HDL-C; LDL-C 289, 145 lants; Proalbumin variants; Functional conse-
quences of albumin variation 289, 45
Free cholesterol; Total cholesterol; Enzyme ther-
mustor; Bile; Serum; Flow injection analysis; Immunoglobulin M:; Waldenstrém’s macroglu-
Gall stones; HDL-C; LDL-C 289, 145 bulinemia; Nephelometry; Enzyme-linked im-
munosorbent assay 289, 173
Functional consequences of albumin variation;
K-ras; Protein kinease te. 8-Hydroxy-
Bisalbuminaemia; Albumin variants; Proalbumin
deoxyguanosine; Lung cancer; Passive smoking
variants; Hypermutability 289, 45
289, 133
Gall stones; Free cholesterol; Total cholesterol;
LDL-C; Free cholesterol; Total cholesterol; En
Enzyme thermistor, Bile; Serum; Flow injection
zyme thermistor; Bile; Serum; Flow injection
analysis; HDL-C; LDL-C 289, 145
analysis; Gall stones; HDL-C 289, 145
Gla-domain; Des-y-carboxyprothrombin; Carboxy-
Lipid; Semen; Prostasomes; Protein; Cholesterol;
lation; -y-Carboxyglutamic acid; Glutamic acid
289, 33 Phospholipid 289, 111
Subject index vol 289 (1999) 187
Lipid peroxidation; Psoriasis; Antioxidants; Vita Pyridinoline cross-links; Thyroid; Biochemical
min E; Beta carotene. 289, 23 bond markers; Thyroid dysfunction 289, 159
Lung cancer; Protein kinease C; 8-Hydroxy Pyridinolines; Ankylosing spondylitis; Osteopenia;
deoxyguanosine; K-ras; Passive smoking 289, Procollagen I propeptides; Telopeptides; Bone
133 sialoprotein 289, 99
Nephelometry; Waldenstr6m’s macroglubulinemia; Rats; Carbon tetrachloride; Oxidative damage
Immunoglobulin M; Enzyme-linked immuno 289, 177
sorbent assay 289, 173
Rifampicin; Serum triacylglycerol; Chlordiazepox
ide; Griseofulvin; Phenytoin; Drug metabolizing
Nephrolithiasis; Cystine; Cystinuria; Colorimetry
enzyme induction 289, |
289, 57
Sebacic acid; Dicarboxylic acids; Dodecanedioic
Osteopenia; Ankylosing spondylitis; Procollagen I acid; High-performance liquid chromatography
propeptides; Pyridinolines; Telopeptides; Bone
Triglycerides 289, 11
sialoprotein 289, 99
Semen, Prostasomes: Lipid; Protein; Cholesterol;
Oxidative damage; Carbon tetrachloride; Rats Phospholipid 289, 111
289, 177
Serum; Free cholesterol; Total cholesterol; Enzyme
Passive smoking; Protein kinease C; 8-Hydroxy thermistor; Bile; Flow injection analysis; Gall
deoxyguanosine; K-ras; Lung cancer 289, 133 stones; HDL-C; LDL-C 289, 145
Phenytoin; Serum triacylglycerol; Chlordiazepox Serum albumin; Bromcresol purple method;
ide; Griseofulvin; Rifampicin; Drug metabolizing Human mercaptalbumin; Human nonmercaptal
enzyme induction 289, 1| bumin; Sodium dodecylsulfate; 5,5‘-dithiobis(2
nitrobenzoic acid) 289, 69
Phospholipid; Semen; Prostasomes; Lipid; Protein
Cholesterol 289, 111 Serum triacylglycerol, Chlordiazepoxide; Griseo
fulvin; Rifampicin; Phenytoin; Drug metaboliz
ing enzyme induction 289, |
Platelet aggregation; Anemarrhenae rhizoma;
Hemolysis, Steroidal saponins 289, 79
Sodium dodecylsulfate; Serum albumin; Brom
cresol purple method; Human mercaptalbumin;
Proalbumin variants; Bisalbuminaemia; Albumin
Human nonmercaptalbumin; 5,5’-dithiobis(2-ni
variants; Hypermutability; Functional conse
trobenzoic acid) 289, 69
quences of albumin variation 289, 45
Soluble interleukin 2 receptors (sIL-2R):
Procollagen I propeptides: Ankylosing
ELAST ; Human 289, 89
spondylitis; Osteopenia; Pyridinolines; Telopep
tides; Bone sialoprotein 289, 99
relopeptides; Ankylosing spondylitis; Osteopenia;
Procollagen I propeptides; Pyridinolines; Bone
Prostasomes; Semen; Lipid; Protein; Cholesterol; sialoprotein 289, 99
Phospholipid 289, 111
Thyroid dysfunction; Thyroid; Biochemical bond
Protein kinease C; 8-Hydroxydeoxyguanosine; K markers; Pyridinoline cross-links 289, 159
ras; Lung cancer; Passive smoking 289, 133
Thyroid; Biochemical bond markers; Pyridinoline
Protein; Semen; Prostasomes; Lipid; Cholesterol; cross-links; Thyroid dysfunction 289, 159
Phospholipid 289, 111
Total cholesterol; Free cholesterol; Enzyme ther
Psoriasis; Lipid peroxidation; Antioxidants; Vita mistor; Bile; Serum; Flow injection analysis;
min E; Beta carotene. 289, 23 Gall stones; HDL-C; LDL-C 289, 145
Subject index vol 289 (1999)
lriglycerides; Dicarboxylic acids; Dodecanedioic Waldenstrém’s macroglubulinemia; Immuno
acid; High-performance liquid chromatography; globulin M; Nephelometry; Enzyme-linked im
Sebacic acid 289, 11 munosorbent assay 289, 173
y-Carboxyglutamic acid; Des~y-carboxyprothrom
bin; Carboxy!ation; Gla-domain; Glutamic acid
Vitamin E Psoriasis; Lipfi d ifp eroxidation; Anti
oxidants; Beta carotene. 289. s2 289, 33